James Chaloupka, PhD, MHS - CPG - Vice President, Medical Director

James Chaloupka

PhD, MHS

CPG

Vice President, Medical Director

New York, NY | United States

Main Specialties: Allergy & Immunology, Cardiovascular Disease, Endocrinology Diabetes & Metabolism, Hematology & Oncology, Oncology, Pharmacology

James Chaloupka, PhD, MHS - CPG - Vice President, Medical Director

James Chaloupka

PhD, MHS

Introduction

Primary Affiliation: CPG - New York, NY , United States

Specialties:

Education

Jun 2006
Cornell University, Weill Medical College
PhD
Pharmacology
May 1997
Johns Hopkins Bloomberg School of Public Health
MHS
Toxicology
May 1994
New York University
BS
Neuroscience

Publications

4Publications

30Reads

4Profile Views

Autoinhibitory regulation of soluble adenylyl cyclase.

Mol Reprod Dev 2006 Mar;73(3):361-8

Department of Pharmacology, Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mrd.20409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644951PMC
March 2006
2 Reads
2.527 Impact Factor

Top co-authors

Jochen Buck
Jochen Buck

Weill Medical College of Cornell University

4
Lonny R Levin
Lonny R Levin

Weill Medical College of Cornell University

4
Fritz A Muhlschlegel
Fritz A Muhlschlegel

Dartmouth Medical School

3
Torsten Klengel
Torsten Klengel

Max Planck Institute of Psychiatry

2
Julian R Naglik
Julian R Naglik

King's College London Dental Institute

1
Claudia Ruoff
Claudia Ruoff

University of Kent

1
Sabine E Eckert
Sabine E Eckert

Roslin Institute and Royal (Dick) School of Veterinary Studies

1
Wei-Jun Liang
Wei-Jun Liang

Research School of Biosciences

1
Estelle Gewiss Mogensen
Estelle Gewiss Mogensen

University of Kent

1